Mechanosensitive Stanniocalcin-1 Suppresses Smooth Muscle Cell Proliferation and Attenuates Experimental Pulmonary Hypertension
Open Access
- 9 October 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 139 (9)
Abstract
BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) is driven by progressive vascular remodeling, particularly smooth muscle cell (SMC) proliferation. Current combination vasodilator therapies have markedly improved outcomes; however, prognosis remains poor in subgroups such as patients with respiratory comorbidities. Elevation of intravascular hydrostatic pressure is a hallmark of IPAH, yet its direct role in pulmonary artery SMCs remains unclear. We aimed to identify pressure-responsive mediators using a newly developed hydrostatic pressurization system to model hypertensive hemodynamics. METHODS: Pulmonary artery SMCs from 4 patients with IPAH were exposed to high hydrostatic pressure (70/40 mm Hg, 60 bpm). Transcriptomic profiling identified differentially expressed genes, which were validated by quantitative polymerase chain reaction. Functional studies included PIEZO1 (piezo type mechanosensitive ion channel component 1) modulation, rhSTC1 (recombinant human stanniocalcin-1) treatment, bromodeoxyuridine incorporation, and Western blotting for cell-cycle regulators. Chronic hypoxia–induced pulmonary hypertension was assessed in wild-type and Stc1 –/– mice by hemodynamic and histological analyses, with or without intratracheal rhSTC1 administration. RESULTS: RNA sequencing revealed STC1 to be a pressure-induced gene in IPAH SMCs. PIEZO1 activation upregulated STC1 , whereas knockdown blunted this response. STC1 was upregulated in IPAH lungs, while rhSTC1 reduced pulmonary arterial SMC proliferation and increased p-p53, p21, and p27 expression. Stc1 –/– mice under hypoxia exhibited significantly higher right ventricular systolic pressure and greater pulmonary arterial medial thickness than wild-type mice. CD68-positive macrophages were increased in Stc1 –/– mice under normoxia and further elevated with hypoxia. Intratracheal administration of rhSTC1 attenuated PAH in wild-type and Stc1 –/– mice. CONCLUSIONS: Elevated hydrostatic pressure drives STC1 expression via PIEZO1, suggesting an adaptive but insufficient protective response in IPAH. Modulation of STC1 (stanniocalcin-1) may represent a potential therapeutic approach.Keywords
This publication has 50 references indexed in Scilit:
- Vascular smooth muscle cell phenotypic switching in atherosclerosisHeliyon, 2024
- Hydrostatic pressure under hypoxia facilitates fabrication of tissue-engineered vascular grafts derived from human vascular smooth muscle cells in vitroActa Biomaterialia, 2023
- The function of Piezo1 in hepatoblastoma metastasis and its potential transduction mechanismHeliyon, 2022
- Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial HypertensionChest, 2022
- Cellular mechanosignaling in pulmonary arterial hypertensionBiophysical Reviews, 2021
- Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancerMolecular and Cellular Endocrinology, 2020
- Golden Ratio and the Proportionality Between Pulmonary Pressure Components in Pulmonary Arterial HypertensionChest, 2019
- Contrasting effects of stanniocalcin-related polypeptides on macrophage foam cell formation and vascular smooth muscle cell migrationPeptides, 2016
- Mesenchymal Stem Cells Correct Inappropriate Epithelial–mesenchyme Relation in Pulmonary Fibrosis Using Stanniocalcin-1Molecular Therapy, 2015
- Suppression of centrosome protein TACC3 induces G1 arrest and cell death through activation of p38–p53–p21 stress signaling pathwayEuropean Journal of Cell Biology, 2015